Verhoef, G.

patient group evi 1 expression leukemia survival evi 1 expression myeloid leukemia treatment 1-evi study cytogenetic mds 1-evi cycle remission myeloid abnormality value table university blood induction mds 1-evi expression daunorubicin square meter chemotherapy result hospital karyotype event-free survival aml patients number postremission erasmus university death escalated-dose group therapy prognostic sample cytarabine analysis square performance status meter conventional-dose group center trial erasmu month 60 years event-free postremission treatment status performance mds 1 expression outcome cytogenetic findings effect factor marrow recovery netherland escalated-dose transcript conventional-dose relapse disease randomization mds 1 level randomized j clin oncol bone marrow samples count monosomal karyotype e ng l postremission therapy event disease-free survival induction cycle